Cite
Defect of CD2- and CD3-mediated activation pathways in T cells of atopic patients: role of interleukin 2.
MLA
Romano, M. F., et al. “Defect of CD2- and CD3-Mediated Activation Pathways in T Cells of Atopic Patients: Role of Interleukin 2.” Cellular Immunology, vol. 139, no. 1, Jan. 1992, pp. 91–97. EBSCOhost, https://doi.org/10.1016/0008-8749(92)90102-u.
APA
Romano, M. F., Valerio, G., Turco, M. C., Spadaro, G., Venuta, S., & Formisano, S. (1992). Defect of CD2- and CD3-mediated activation pathways in T cells of atopic patients: role of interleukin 2. Cellular Immunology, 139(1), 91–97. https://doi.org/10.1016/0008-8749(92)90102-u
Chicago
Romano, M F, G Valerio, M C Turco, G Spadaro, S Venuta, and S Formisano. 1992. “Defect of CD2- and CD3-Mediated Activation Pathways in T Cells of Atopic Patients: Role of Interleukin 2.” Cellular Immunology 139 (1): 91–97. doi:10.1016/0008-8749(92)90102-u.